ライフサイエンスコーパス: cryptoxanthin

1 for beta-carotene, alpha-carotene, and beta-cryptoxanthin).

2 arotenoids, alpha-carotene, ss-carotene, and cryptoxanthin).

3 ein, all-trans-zeaxanthin and all-trans-beta-cryptoxanthin).

4 n C, alpha-carotene, beta-carotene, and beta-cryptoxanthin.

5 1)% after controlling for vitamin E and beta-cryptoxanthin.

6 .44 for beta-carotene, and r = 0.50 for beta-cryptoxanthin.

7 utein and 1.68 (95% CI: 0.99, 2.86) for beta-cryptoxanthin.

8 a-carotene, lutein, alpha-carotene, and beta-cryptoxanthin.

9 association was seen with vitamin E and beta-cryptoxanthin.

10 erved, with the highest increase in a- and B-cryptoxanthin.

11 with the highest increase in alpha- and beta-cryptoxanthin.

12 esponse and the colonic availability of beta-Cryptoxanthin.

13 oids beta-carotene, alpha-carotene, and beta-cryptoxanthin.

14 5% CI: 0.84, 0.96; P-trend < 0.001) for beta-cryptoxanthin.

15 oxy xanthophylls lutein, zeaxanthin and beta-cryptoxanthin.

16 from 0.03 for beta-carotene to 0.40 for beta-cryptoxanthin.

17 nged from 0.13 for lycopene to 0.51 for beta-cryptoxanthin.

18 sors alpha-carotene, beta-carotene, and beta-cryptoxanthin.

19 g), B-carotene (0.82 - 1.49 mg/100 g), and B-cryptoxanthin (0.07 - 0.11 mg/100 g) were identified by

20 ha-carotene, 0.35; beta-carotene, 0.28; beta-cryptoxanthin, 0.35; lutein/zeaxanthin, 0.28; lycopene,

21 carotene, 0.95 (95% CI: 0.70, 1.29) for beta-cryptoxanthin, 0.82 (95% CI: 0.60, 1.12) for lycopene, 0

22 .5, and 54.6 micro mol/L, respectively; beta-cryptoxanthin: 0.12, 0.16, and 0.16 micro mol/L, respect

23 ycopene (28%), lutein/zeaxanthin (17%), beta-cryptoxanthin (15%), total carotenoids (16%), serum beta

24 (5-fold), alpha-carotene (19-fold), and beta-cryptoxanthin (2-fold) concentrations; total-body vitami

25 eta-carotene (29.4), zeaxanthin (1.28), beta-cryptoxanthin (2.8), phytoene (18.68) and phytofluene (7

26 ene (1483%), alpha-carotene (145%), and beta-cryptoxanthin (67%) (P < or = 0.0001).

27 The concentrations of plasma lutein, cryptoxanthin, alpha-carotene, 13-cis-beta-carotene, all

28 otective factor(s) against lung cancer; that cryptoxanthin, alpha-carotene, and ascorbic acid need to

29 Serum levels of lycopene, lutein, cryptoxanthin, alpha-carotene, and beta-carotene were as

30 scores for other carotenoids, including beta-cryptoxanthin, alpha-carotene, and beta-carotene, were a

31 k, whereas no association was found for beta-cryptoxanthin, alpha-carotene, and beta-carotene.

32 lasma and BMC concentrations of lutein, beta-cryptoxanthin, alpha-carotene, and beta-carotene.

33 toene, phytofluene, lutein, zeaxanthin, beta-cryptoxanthin, alpha-carotene, beta-carotene and lycopen

34 association between serum carotenoids (beta-cryptoxanthin, alpha-carotene, beta-carotene, lutein/zea

35 difference in beta-carotene relative to beta-cryptoxanthin and 36% of the variation and 4-fold differ

36 lasma and lipoprotein concentrations of beta-cryptoxanthin and alpha- and beta-carotene than did men.

37 Levels of lutein, zeaxanthin, beta-cryptoxanthin and beta-carotene in hexane extracts were

38 were generated for lutein, zeaxanthin, beta-cryptoxanthin and beta-carotene in kaki, peach and apric

39 ibutors to TEAC activity, while lutein, beta-cryptoxanthin and beta-carotene were primary contributor

40 minor carotenoids were antheraxanthin, beta-cryptoxanthin and beta-carotene, while zeaxanthin was ab

41 evels were 15-fold higher than those of beta-cryptoxanthin and beta-carotene.

42 Recent epidemiological data on beta-cryptoxanthin and cardiovascular disease are lacking.

43 thophylls such as lutein, zeaxanthin or beta-cryptoxanthin and carotenes such as beta-carotene, which

44 s beta-carotene, alpha-carotene, capsorubin, cryptoxanthin and cryptoflavin in comparison to the conv

45 ) negative phenotypic correlations between B-cryptoxanthin and five CMTs: body mass index (- 0.22), w

46 among women reporting intake values of beta-cryptoxanthin and lutein/zeaxanthin in the upper 2 quart

47 il) on the in vitro bioaccessibility of beta-Cryptoxanthin and phytosterols, a MFGM containing bevera

48 ween higher intake of beta-carotene and beta-cryptoxanthin and risk of hearing loss.

49 ntioxidants were modeled together, only beta-cryptoxanthin and supplemental zinc were statistically s

50 ntioxidant micronutrients, particularly beta-cryptoxanthin and supplemental zinc, and possibly diets

51 tene, lycopene, lutein, zeaxanthin, and beta-cryptoxanthin and the risk of colon cancer.

52 gative associations with kidney stones: beta-cryptoxanthin and two forms of sphingomyelin.

53 In addition, B-carotene, lutein, B-cryptoxanthin and violaxanthin had also been quantified.

54 In addition, beta-carotene, lutein, beta-cryptoxanthin and violaxanthin had also been quantified.

55 nts of mono-esterified lauric acid with beta-cryptoxanthin and with cryptocapsin.

56 itamin A carotenoids (beta-carotene and beta-cryptoxanthin) and capsanthin were present at highest co

57 concentrations (lutein + zeaxanthin and beta-cryptoxanthin) and hydrocarbon carotenoids (lycopene, al

58 , lutein plus zeaxanthin, lycopene, and beta-cryptoxanthin) and risk of HNC and HNC subtypes in a lar

59 ptoxanthin (standard hypocaloric diet + beta-cryptoxanthin), and control (standard hypocaloric diet +

60 carotene, 0.91 (95% CI: 0.46, 1.81) for beta-cryptoxanthin, and 1.35 (95% CI: 0.68, 2.69) for lutein/

61 wk apart were > or = 0.89 for lycopene, beta-cryptoxanthin, and alpha- and beta-carotene.

62 sayed for ascorbic acid, beta-carotene, beta-cryptoxanthin, and alpha- and gamma-tocopherol.

63 alpha-carotene, beta-carotene, lutein, beta-cryptoxanthin, and ascorbic acid increased by more in th

64 e oxidative cleavage of alpha-carotene, beta-cryptoxanthin, and beta-apo-8'-carotenal to yield retina

65 Furthermore, the BA of lutein, beta-cryptoxanthin, and beta-cryptoxanthin esters was shown t

66 ups (13.0%, 17.4%, and 0.0% in HP-diet, beta-cryptoxanthin, and control groups, respectively; p < 0.0

67 Higher intakes of beta-carotene, beta-cryptoxanthin, and folate, whether total or from diet, a

68 ricans had higher mean serum vitamin C, beta-cryptoxanthin, and lutein + zeaxanthin but lower folate

69 tions of alpha-carotene, beta-carotene, beta-cryptoxanthin, and lutein+zeaxanthin were 0.25, 0.29, 0.

70 nd intakes of vitamin C, beta-carotene, beta-cryptoxanthin, and lutein-zeaxanthin from food (P < 0.05

71 kes of vitamins C and E, beta-carotene, beta-cryptoxanthin, and lutein-zeaxanthin from food, or a die

72 kes of vitamins C and E, beta-carotene, beta-cryptoxanthin, and lutein-zeaxanthin from food: 0.27 (0.

73 ycopene, alpha-carotene, beta-carotene, beta-cryptoxanthin, and lutein/zeaxanthin were similar in cas

74 ctors of beta-carotene, alpha-carotene, beta-cryptoxanthin, and lutein/zeaxanthin.

75 ha-carotene, beta-carotene, zeaxanthin, beta-cryptoxanthin, and lycopene.

76 e retina accumulated zeaxanthin, lutein, and cryptoxanthin, and preferentially absorbed zeaxanthin (P

77 Lycopene, beta-cryptoxanthin, and vitamin C were not associated with re

78 te specificity and can esterify lutein, beta-cryptoxanthin, and zeaxanthin using multiple acyl donors

79 alpha-carotene, beta-carotene, lutein, beta-cryptoxanthin, and zeaxanthin, showed no association wit

80 spiratory health and that vitamin E and beta-cryptoxanthin appear to be stronger correlates of lung f

81 ith the exception of this activity with beta-cryptoxanthin, BCO2 cleaves specifically at the 9'-10' b

82 95% CI: 0.07, 0.28 SU; P = 0.005), and beta-cryptoxanthin (beta = 0.13 SU; 95% CI: 0.05, 0.21 SU; P

83 ha-carotene (beta,epsilon-carotene) and beta-cryptoxanthin (beta,beta-carotene-3-ol), produces noncan

84 ficantly lower among cases than controls for cryptoxanthin, beta-carotene, and lutein/zeaxanthin with

85 In general, beta-cryptoxanthin (betaCX) had higher retention than beta-ca

86 rgistic relationships were observed for beta-cryptoxanthin concentration after irradiation.

87 t to between-subject variance ratio for beta-cryptoxanthin concentration was higher (0.23; 95% CI: 0.

88 Here, we quantified serum lycopene and B-cryptoxanthin concentrations in approximately 580 childr

89 ficantly lower plasma ascorbic acid and beta-cryptoxanthin concentrations than did nonsmokers and pas

90 carotenoid, alpha-carotene, ss-carotene, and cryptoxanthin concentrations than did those who lived in

91 r 0 sum of provitamin A carotenoids and beta-cryptoxanthin concentrations were associated with maximu

92 There was a trend toward lower adjusted beta-cryptoxanthin concentrations with increasing level of fi

93 rotenoids, alpha- and beta-carotene and beta-cryptoxanthin, constituted 51% of median total carotenoi

94 The potential of beta-cryptoxanthin (CX)-rich foods to form vitamin A (VA) in

95 a-Cryptoxanthin, tentatively identified beta-Cryptoxanthin esters and the ratio cis-/trans-beta-carot

96 e BA of lutein, beta-cryptoxanthin, and beta-cryptoxanthin esters was shown to be superior to that of

97 is not present in the MS(2) spectrum of beta-cryptoxanthin esters.

98 In all acidic media, beta-cryptoxanthin exhibited the lowest degradation rates fol

99 o tailor asymmetric carotenoids such as beta-cryptoxanthin for vitamin A production.

100 ade 0 hepatic steatosis) in HP-diet and beta-cryptoxanthin group (82.6%) was also higher than other g

101 -treat population (N = 92), HP-diet and beta-cryptoxanthin group experienced greater 12-week reductio

102 otene, lycopene, lutein/zeaxanthin, and beta-cryptoxanthin, have been examined in a number of epidemi

103 evels that were 27% (lycopene) to 178% (beta-cryptoxanthin) higher than those of subjects in the lowe

104 beta-Cryptoxanthin, however, undergoes an initial eccentric c

105 ta-cryptoxanthin (hypocaloric HP-diet + beta-cryptoxanthin), HP-diet (hypocaloric HP-diet + placebo),

106 mized into 4 arms (n = 23): HP-diet and beta-cryptoxanthin (hypocaloric HP-diet + beta-cryptoxanthin)

107 e, beta-carotene, lutein, lycopene, and beta-cryptoxanthin in 2 large cohorts.

108 The fatty acids esterifying beta-cryptoxanthin in mandarins were lauric, myristic, palmit

109 a hypocaloric HP-diet supplemented with beta-cryptoxanthin in NAFLD.

110 ffects of high protein (HP)-diet and/or beta-cryptoxanthin in non-alcoholic fatty liver disease (NAFL

111 arly beta-carotene, alpha-carotene, and beta-cryptoxanthin, in both the supplemented and unsupplement

112 and serum concentrations of lutein and beta-cryptoxanthin increased across the groups in a dose-depe

113 ciation with beta-carotene, lutein, and beta-cryptoxanthin intakes were inverse but not significant.

114 m differential subcellular trafficking: beta-cryptoxanthin is transported to mitochondria via Aster-B

115 increased as follows: beta-carotene < alpha-cryptoxanthin < beta-cryptoxanthin < lutein < zeaxanthin

116 : beta-carotene < alpha-cryptoxanthin < beta-cryptoxanthin < lutein < zeaxanthin.

117 tenoid peaks (alpha- and beta-carotene, beta-cryptoxanthin, lutein, and lycopene) plus alpha- and gam

118 carotenoids (alpha- and beta-carotene, beta-cryptoxanthin, lutein, and lycopene), retinol, and alpha

119 the lowest serum vitamin B-12, folate, beta-cryptoxanthin, lutein, and zeaxanthin concentrations.

120 s fraction of alpha- and beta-carotene, beta-cryptoxanthin, lutein, lycopene and zeaxanthin in minima

121 tenoids (alpha-carotene, beta-carotene, beta-cryptoxanthin, lutein, lycopene and zeaxanthin) in parti

122 arotene, beta-carotene, total carotene, beta-cryptoxanthin, lutein, lycopene, retinol, and ascorbic a

123 entrations of alpha-carotene, beta-carotene, cryptoxanthin, lutein/zeaxanthin, and lycopene in 40- to

124 levels of antioxidants alpha-carotene, beta-cryptoxanthin, lutein/zeaxanthin, and lycopene were sign

125 tenoids (alpha-carotene, beta-carotene, beta-cryptoxanthin, lutein/zeaxanthin, and lycopene) in a ran

126 mins C and E, retinol, and carotenoids (beta-cryptoxanthin, lutein/zeaxanthin, beta-carotene, and lyc

127 t associations of vitamin C, vitamin E, beta-cryptoxanthin, lutein/zeaxanthin, beta-carotene, and ret

128 either project for alpha- and beta-carotene, cryptoxanthin, lutein/zeaxanthin, lycopene, alpha-tocoph

129 takes of alpha-carotene, beta-carotene, beta-cryptoxanthin, lutein/zeaxanthin, lycopene, folate, and

130 94, the carotenoids lutein, zeaxanthin, beta-cryptoxanthin, lycopene, alpha-carotene, and beta-carote

131 Lutein, beta-cryptoxanthin, lycopene, alpha-carotene, retinol, and al

132 takes of beta-carotene, alpha-carotene, beta-cryptoxanthin, lycopene, and lutein + zeaxanthin and bre

133 idual carotenoids (a-carotene, B-carotene, B-cryptoxanthin, lycopene, and lutein + zeaxanthin)] with

134 tenoids (alpha-carotene, beta-carotene, beta-cryptoxanthin, lycopene, and lutein) and TB incidence wa

135 intake (alpha-carotene, beta-carotene, beta-cryptoxanthin, lycopene, and lutein+zeaxanthin) with BMD

136 ncluding alpha-carotene, beta-carotene, beta-cryptoxanthin, lycopene, and lutein-zeaxanthin, blood li

137 h levels of circulating alpha-carotene, beta-cryptoxanthin, lycopene, and lutein/zeaxanthin were asso

138 evels of alpha-carotene, beta-carotene, beta-cryptoxanthin, lycopene, and lutein/zeaxanthin were meas

139 tenoids (alpha-carotene, beta-carotene, beta-cryptoxanthin, lycopene, and lutein/zeaxanthin) to level

140 nd E and alpha-carotene, beta-carotene, beta-cryptoxanthin, lycopene, lutein, and zeaxanthin from foo

141 carotenoids (alpha- and beta-carotene, beta-cryptoxanthin, lycopene, lutein, and zeaxanthin) were me

142 n plasma alpha-carotene, beta-carotene, beta-cryptoxanthin, lycopene, lutein/zeaxanthin, retinol, alp

143 pherols), and carotenoid (lutein/zeaxanthin, cryptoxanthins, lycopene, and alpha- and beta-carotene)

144 Except for alpha-carotene and cryptoxanthin, none of the model carotenoids or retinol

145 ix weeks provoked an increment in serum beta-Cryptoxanthin of 38.9mug/dl (CI 95%; 31.0, 46.8; p<0.001

146 f a- and B-carotenoids rather than that of B-cryptoxanthin or lycopene had maximal effects on ISI.

147 .54 [0.38-0.78]; P(trend) = .003), and alpha-cryptoxanthin (OR = 0.53 [0.36-0.78]; P(trend) = .003) w

148 carotene (OR, 0.91; 95% CI, 0.86-0.96), beta cryptoxanthin (OR, 0.91; 95% CI, 0.84-0.99), lutein/zeax

149 CI: 0.1, 1.2; P = 0.13 for linear trend) and cryptoxanthin (OR: 0.3; 95% CI: 0.1, 1.3; P = 0.11 for l

150 -carotene, beta-carotene, lycopene, and beta-cryptoxanthin) or vitamin A after other potential risk f

151 0.002), beta-carotene (P < 0.001), and beta-cryptoxanthin (P < 0.001) concentrations.

152 < 0.001), 9.1 and 8.0 microg/liter for beta-cryptoxanthin (p < 0.001), and 50.6 and 46.8 microg/lite

153 had higher alpha-carotene (P < 0.001), beta-cryptoxanthin (P < 0.001), and lutein and zeaxanthin (P

154 nd adolescents had significantly higher beta-cryptoxanthin (P < 0.001), lutein and zeaxanthin (P < 0.

155 d carotenoid esters, beta-carotene, and beta-cryptoxanthin palmitate were the most abundant in peels

156 oactive components (lutein, zeaxanthin, beta-cryptoxanthin, phytate, tannin and vitamin C) and colour

157 otenoids (capsanthin, phytoene, lutein, beta-cryptoxanthin), polyphenols content (p-coumaric, ferulic

158 een anticholinergic activity and all-trans-B-cryptoxanthin, quercetin-3-O-glucoside, isorhamnetin-3-O

159 e (r = 0.40), beta-carotene (r = 0.28), beta-cryptoxanthin (r = 0.41), lutein (r = 0.23), and vitamin

160 were also consistently detected in BCO2-beta-cryptoxanthin reaction mixtures.

161 Auroxanthin and beta-cryptoxanthin represented around 50% of total carotenoid

162 ein, all-trans-zeaxanthin and all-trans-beta-cryptoxanthin, respectively.

163 carotene, lycopene, lutein, zeaxanthin, beta-cryptoxanthin), retinol, and tocopherols (alpha-tocopher

164 carotene, lycopene, lutein, zeaxanthin, beta-cryptoxanthin, retinol, alpha-tocopherol, gamma-tocopher

165 e there was an inverse association with beta-cryptoxanthin (RR = 0.59, 95% CI: 0.39, 0.90; p-trend =

166 A hypocaloric HP-diet supplemented with beta-cryptoxanthin safely and efficaciously improves NAFLD.

167 stones in both HPFS and NHS II cohorts: beta-cryptoxanthin, sphingomyelin (d18:2/24:1, d18:1/24:2), a

168 P-diet (hypocaloric HP-diet + placebo), beta-cryptoxanthin (standard hypocaloric diet + beta-cryptoxa

169 range hybrid maize; lutein, zeaxanthin, beta-cryptoxanthin, tannin and vitamin C increased with an in

170 In faeces, free beta-Cryptoxanthin, tentatively identified beta-Cryptoxanthin

171 genated carotenoids (lutein, zeaxanthin, and cryptoxanthin), three hydro-carbon carotenoids (alpha-ca

172 tegories of intake ranged from 0.80 for beta-cryptoxanthin to 0.89 for alpha-carotene and lutein-zeax

173 s-zeaxanthin, total trans-lutein/zeaxanthin, cryptoxanthin (total and beta), total trans-lycopene and

174 carotene, lycopene, lutein/zeaxanthin, alpha-cryptoxanthin, total carotenoids, retinol, alpha-tocophe

175 -carotene, beta-carotene, lycopene, and beta-cryptoxanthin), vitamin A, and retinol were not associat

176 -carotene, lutein/zeaxanthin, lycopene, beta-cryptoxanthin, vitamin A, serum beta-carotene, and serum

177 17, which is in line with the fact that beta-cryptoxanthin was mostly esterified and not free (uneste

178 A decrease of beta-cryptoxanthin was observed at higher temperatures, where

179 tamin A carotenoids, beta-carotene, and beta-cryptoxanthin were each inversely associated with a decl

180 tandard deviation of serum vitamin E or beta-cryptoxanthin were equivalent to the negative influence

181 Violaxanthin and B-cryptoxanthin were found as major carotenoids in the ora

182 The concentrations of lycopene and B-cryptoxanthin were highly heritable [h(2) = 0.98, P = 7

183 As for FEV(1)%, vitamin E and beta-cryptoxanthin were most strongly related to FVC% when al

184 seedlings whereas CHO-folate vitamers and B-cryptoxanthin were much lower in adult plants.

185 ietary intakes of lutein+zeaxanthin and beta-cryptoxanthin were not associated with breast cancers de

186 hough the pooled RRs for quintile 5 for beta-cryptoxanthin were not significant, inverse trends were

187 ed carotenoids (lutein, zeaxanthin, and beta-cryptoxanthin) were detected at electrical potential set

188 cis isomers, cis anhydrolutein, and cis beta-cryptoxanthin) were inversely associated with 15-F(2t)-I

189 between the esters of zeinoxanthin and beta-cryptoxanthin, which were undifferentiated to date durin

190 xanthophylls (cis-violaxanthin, lutein, beta-cryptoxanthin, zeaxanthin and cis-antheraxanthin) were i